Toward consistent local control of certain malignant tumors. Endoradiotherapy with iridium 192.
D001943:Breast Neoplasms / Q000532:radiotherapy; D002280:Basal Cell Carcinoma / Q000532:radiotherapy; D002294:Carcinoma, Squamous Cell / Q000532:radiotherapy; D004428:Ear Neoplasms / Q000532:radiotherapy; D005260:Female; D006258:Head and Neck Neoplasms / Q000532:radiotherapy; D006801:Humans; D007495:Iridium / Q000008:administration & dosage*; D008048:Lip Neoplasms / Q000532:radiotherapy; D008297:Male; D008722:Methods; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control*; D009369:Neoplasms / Q000532:radiotherapy*; D009669:Nose Neoplasms / Q000532:radiotherapy; D010157:Palatal Neoplasms / Q000532:radiotherapy; D010412:Penile Neoplasms / Q000532:radiotherapy; D011868:Radioisotopes / Q000008:administration & dosage; D012878:Skin Neoplasms / Q000532:radiotherapy; D013679:Technology, Radiologic; D014062:Tongue Neoplasms / Q000532:radiotherapy; D014067:Tonsillar Neoplasms / Q000532:radiotherapy; D014523:Urethral Neoplasms / Q000532:radiotherapy; D014625:Vaginal Neoplasms / Q000532:radiotherapy
D011868:Radioisotopes; D007495:Iridium